Chlortetracycline

金霉素

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameChlortetracycline
Drug Alias Nameclortetraciclina氯四环素氯四环霉素chlortetracyclinum金霉素碱
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Tetracycline antibiotics
Mechanisms of Action30S ribosomal subunit inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsBurnsSkin DiseasesBlepharitis +[4] 
Global Approved IndicationsBurnsSkin DiseasesBlepharitis +[4] 
Approved Indications in ChinaBurnsSkin DiseasesBlepharitis +[4] 
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Pharmaceutical Group Co LtdTianjin Pharmaceutical Peace (Tianjin) Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBurnsSkin DiseasesBlepharitis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeA01AB21D06AA02J01AA03 +[4] 
Related LinksWikipediaDrugBankKEGG